Condition: Severe Hypoglycemia · Type1diabetes · Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain
The GLUREDIA study investigates the counter-regulatory response (CRR) during hypoglycemia in children with type 1 diabetes (T1D). Hypoglycemia can lead to severe symptoms, but is normally counteracted by CRR, corresponding to the secretion of hormones to maintain normoglycemia. Hypoglycemia is common in T1DM but some patients develop severe hypoglycemia as a result of CRR dysfunction. Despite several studies in adults, the presence of CRR dysfunction remains unpredictable and not well understood. The objective of GLUREDIA is therefore to describe and predict the evolution of CRR in children with T1DM.
This description comes directly from the study's public registry record.
Philippe Lysy, Pr · 027641370 · antoine.harvengt@saintluc.uclouvain.be
Antoine Harvengt, Dr · 027641370 · antoine.harvengt@saintluc.uclouvain.be
Always discuss trial participation with your own doctor first.
| Clinique Universitaires Saint Luc | Brussels, Woluwe-saint-lambert, Belgium | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06770621